|
Volumn 25, Issue 5, 2000, Pages 480-487
|
Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: Results from a prospective, crossover, double-blind, randomized study
a a a a a |
Author keywords
Bupivacaine ropivacaine; Intrathecal; Refractory pain
|
Indexed keywords
BUPIVACAINE;
ROPIVACAINE;
ADULT;
AGED;
ANALGESIA;
ARTICLE;
CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFECT;
FEMALE;
GAIT DISORDER;
HUMAN;
MALE;
PAIN;
PARESIS;
PARESTHESIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
URINE RETENTION;
|
EID: 0033795133
PISSN: 10987339
EISSN: None
Source Type: Journal
DOI: 10.1053/rapm.2000.8574 Document Type: Article |
Times cited : (35)
|
References (20)
|